Skip to content

Treace Medical Concepts, Inc. TMCI Commitments & Contingencies

Commitments & Contingencies at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$0
Hagerty logo
HagertyHGTY
$0
PEW
GrabAGun Digital Holdings Inc.PEW
$0
Global Net Lease logo
Global Net LeaseGNL
$0
W&T Offshore logo
W&T OffshoreWTI
$25.75M+27.5%
FIP
FTAI Infrastructure Inc.FIP
$0

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-22.3%
Enterprise value$320.25M-19.0%
P/S1.3×-0.3×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Reported directly by Treace Medical Concepts, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommitmentsAndContingencies.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed November 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s commitments & contingencies.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s commitments & contingencies?
Treace Medical Concepts, Inc. (TMCI) reported commitments & contingencies of $0 in Q3 2023.